Distinguished in X-Linked Lymphoproliferative Disease

Xiaodong D. Zhao

State Key Laboratory Of Trauma And Chemical Poisoning, 
Daping, CN 
Distinguished in X-Linked Lymphoproliferative Disease
State Key Laboratory Of Trauma And Chemical Poisoning, 
Daping, CN 
OverviewLocationsClinical Research

Overview

Xiaodong Zhao practices in Daping, China. Zhao is rated as a Distinguished expert by MediFind in the treatment of X-Linked Lymphoproliferative Disease. Their top areas of expertise are Wiskott-Aldrich Syndrome, Primary Immunodeficiency (PID), Infantile Neutropenia, and X-Linked Lymphoproliferative Disease.

Their clinical research consists of co-authoring 127 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of X-Linked Lymphoproliferative Disease.

Locations

State Key Laboratory Of Trauma And Chemical Poisoning, Daping, China
Other Locations
Changchun, China
Ministry Of Education Key Laboratory Of Child Development And Disorders Chongqing Key Laboratory Of Child Infection And Immunity China International Science And Technology Cooperation Base Of Child Development And Critical Disorders Chongqing China, Chongqing, China
Yantai, 264005, China
Gongzhuling, 136100, China
Hangzhou, 310000, China
Guangdong Provincial Key Laboratory Of Research In Structural Birth Defect Disease, Guangzhou, China
Shandong Provincial Key Laboratory Of Animal Biotechnology And Disease Control And Prevention, 61 Daizong Street, Tai'an, 271018, China
Jilin, 130118, China
Chongqing Key Laboratory Of Pediatrics, No. 136, Zhongshan 2nd Road, Zhongshan, 400014, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

127 Total Publications

Loss of ACSL1 fuels ferroptosis resistance in clear cell renal carcinoma.
Loss of ACSL1 fuels ferroptosis resistance in clear cell renal carcinoma.
Journal: Cancer biology & therapy
Published: October 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhao's expertise for a condition
ConditionClose
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile